Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Sorafenib | Case report

Decitabine/sorafenib

Lack of efficacy and cerebral haemorrhage

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Feng R, et al. Low-dose decitabine for previously untreated acute myeloid leukemia ineligible for intensive chemotherapy aged 65 years or older: a prospective study based on comprehensive geriatric assessment. Therapeutic Advances in Hematology 14 : 1-14, Jan 2023. Available from: URL: https://dx.doi.org/10.1177/20406207231208979 Feng R, et al. Low-dose decitabine for previously untreated acute myeloid leukemia ineligible for intensive chemotherapy aged 65 years or older: a prospective study based on comprehensive geriatric assessment. Therapeutic Advances in Hematology 14 : 1-14, Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1177/​2040620723120897​9
Metadata
Title
Decitabine/sorafenib
Lack of efficacy and cerebral haemorrhage
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56146-2

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Evolocumab

Case report

Vancomycin

Case report

Methotrexate

Case report

Multiple drugs

Case report

Alpelisib